TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab
TP53 突变与接受西妥昔单抗和帕博利珠单抗治疗的晚期 RAS 野生型结直肠腺癌患者的疾病控制改善相关
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70434
Fountzilas, Christos; Rosario, Spencer; Witkiewicz, Agnieszka K; Withers, Henry G; Bajor, David L; Mukherjee, Sarbajit; Saltzman, Joel; Maguire, Orla; Minderman, Hans; Chatley, Sarah; Tarquini, Mary Lynn; Whitworth, Amy; Jurcevic, Jennifer; Hsiao, Hua-Hsin; Knudsen, Erik S; Muhitch, Jason B; Abrams, Scott I; Kalinski, Pawel; Segal, Brahm H; Bakin, Andrei; Yuan, Guangwei; Wang, Chong; Attwood, Kristopher; Iyer, Renuka; Boland, Patrick M